# FDA Inspection 802830 - Biotest Pharmaceuticals - October 11, 2012

Source: https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals/06d18ffe-b7df-496f-88b1-6c992aa9246c
Source feed: FDA_Inspections

> FDA Inspection 802830 for Biotest Pharmaceuticals on October 11, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 802830
- Company Name: Biotest Pharmaceuticals
- Inspection Date: 2012-10-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1262757 - 2025-02-13](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals/416116f6-d28b-4423-94b4-a708e301a00e)
- [FDA Inspection 1262757 - 2025-02-13](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals/8eee8ab6-cf7b-45c8-b3fc-29847ceacd14)
- [FDA Inspection 1069240 - 2018-10-16](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals/92fceb0a-fa18-4361-8296-9f12305fa748)
- [FDA Inspection 986994 - 2016-10-05](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals/6cd0d815-db52-469e-b769-86c8238403c4)
- [FDA Inspection 921672 - 2015-04-09](https://www.globalkeysolutions.net/records/fda_inspections/biotest-pharmaceuticals/05666fbe-9412-4350-a388-dee19151f1f6)

Company: https://www.globalkeysolutions.net/companies/biotest-pharmaceuticals/7433d234-46a0-4680-b44d-18b57b7f363d

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d